Wednesday, April 24, 2024
3:30 PM - 7:00 PM ET
Mitigating Biotech-Startup Cyberattacks
Biological and medical information is more valuable than other types of data; health information on the black market is worth 300x that of credit card details. Big Data and Machine Learning have accelerated early-stage/emerging life-science organizations’ capabilities of obtaining investor attention – while also making that sector one of the most targeted for cyber criminals. Biotech startups rely on health information collected from research collaborators, internet-connected medical devices, research laboratories and other provider sources to advance their initiatives. Threat actors continue to expose vulnerabilities, successfully hijacking data sources and other repositories – threatening exposure.
Event Details
Wednesday, April 24
3:30 – 7:00 PM EST
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
One Financial Center 40th Floor | Boston, MA 02111
In this informative session, cybersecurity and privacy professionals from Withum and Mintz will cover:
Why Biotech-Startups need to take cybersecurity seriously (no matter what stage).
Learn practical steps to help protect intellectual property, ensuring scientific data remains trustworthy.
Understanding the evolving regulatory/legislative landscape for privacy and data security.
Incident Response: how to ensure timely recovery, while limiting exposure.
Regulatory and Notification Obligations: be aware of reporting and notification obligations resulting from an incident.
Agenda:
3:30 – 4:00 PM Registration and networking
4:00 – 4:45 PM Panel presentation
4:45 – 5:00 PM Q&A session
5:00 – 5:30 PM Cocktails and appetizers
5:30 – 6:30 PM Pop up pitches with Q&A
6:30 – 7:00 PM Networking
7:00 PM Program close
Please RSVP on or before April 17.
Questions? Contact Alexis Blacknik at ablacknik@withum.com.
Thanks to Withum for the listing and graphics for this virtual startup event.